Ads
related to: Pfizer- World-Class Products
Discover more about our FDA-
approved treatment options.
- Science and Innovation
View our approach to finding
solutions for cancer's complexities
- Astellas Pharma Support
Learn about our Support Solutions
and find helpful enrollment forms.
- Patient Commitment
Our Patient Centricity Team aims to
change the course of cancer care.
- World-Class Products
Search results
Pfizer Inc. (PFE) Becoming More Attractive for Investors – Knox Daily
Knox Daily· 4 days agoPfizer Inc.’s recent filing unveils that its Director Gottlieb Scott acquired Company’s shares for reported $79401.0 on Dec 15 ’23. In the deal valued at $26.47 per share, ...
EU regulators approve Pfizer antibiotic Emblaveo (NYSE:PFE)
Seeking Alpha· 4 days agoEU regulators have approved Pfizer (PFE) and AbbVie’s (ABBV) antibiotic product Emblaveo for the...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 3 days agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
GlaxoSmithKline Sues Pfizer and BioNTech Over Covid-19 Vaccine Technology
US News & World Report· 20 hours agoUS News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
Zacks· 2 days agoFree Report) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook is important in assessing ...
Pfizer (PFE) Rises Higher Than Market: Key Facts
Zacks· 4 days agoFree Report) closed at $26.26 in the latest trading session, marking a +1% move from the prior day. This move outpaced the S&P 500's daily gain of 0.87%. In that same time, the Medical sector ...
J.W. Cole Advisors Inc. Boosts Stake in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 5 days agoJ.W. Cole Advisors Inc. raised its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 25.3% during the fourth quarter, according to its most recent disclosure with the Securities ...
Pfizer (NYSE:PFE) Trading 0.9% Higher
ETF DAILY NEWS· 5 days agoShares of Pfizer Inc. (NYSE:PFE – Get Free Report) traded up 0.9% during mid-day trading on Friday . The stock traded as high as $25.66 and last traded at $25.62. 10,092,678 ...
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
Zacks via Yahoo Finance· 7 days agoPfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good...
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 3 days agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...